Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geneva Bioinformatics
Geneva, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
Geneva Bioinformatics (GeneBio) was a leading provider of bioinformatics software solutions for the life science sector, with expertise particularly in mass spectrometry-based protein and small molecule characterization and proteome imaging. Its activities were taken over by the SIB Swiss Institute of Bioinformatics in early 2021[4].
- Industry
- Drug Discovery Services
02
Partnerships
SIB Swiss Institute of BioinformaticsGeneva University Hospitals
Beyond the preview
Go deeper on Geneva Bioinformatics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Geneva Bioinformatics.